4//SEC Filing
RESMED INC 4
Accession 0001140361-12-025920
$RMDCIK 0000943819operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:26 PM ET
Size
15.1 KB
Accession
0001140361-12-025920
Insider Transaction Report
Form 4
RESMED INCRMD
QUINN MICHAEL A
Director
Transactions
- Exercise/Conversion
ResMed Common Stock
2012-05-14$9.80/sh+12,000$117,576→ 314,000 total - Exercise/Conversion
ResMed Common Stock Options
2012-05-14−24,000→ 0 totalExercise: $23.09From: 2007-11-10Exp: 2013-11-10→ ResMed Common Stock (24,000 underlying) - Sale
ResMed Common Stock
2012-05-14$33.30/sh−12,000$399,619→ 302,000 total - Exercise/Conversion
ResMed Common Stock Options
2012-05-14−24,000→ 12,000 totalExercise: $9.80From: 2004-07-07Exp: 2013-07-07→ 24,000 (24,000 underlying) - Sale
ResMed Common Stock
2012-05-14$33.26/sh−12,000$399,120→ 302,000 total - Exercise/Conversion
ResMed Common Stock
2012-05-14$23.09/sh+12,000$277,140→ 314,000 total
Holdings
- 6,600(indirect: Kaylara ATF Straflo Pension Fund)
ResMed Common Stock
- 400,000
ASX CDIs
Footnotes (4)
- [F1]Represents date options first became exercisable. Options vest 1/12 per month and are fully vested at one year.
- [F2]Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.
- [F3]This transaction was executed in multiple trades at prices ranging from $33.26 and 33.31. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.
- [F4]Previously reported as 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.
Documents
Issuer
RESMED INC
CIK 0000943819
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000943819
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:26 PM ET
- Size
- 15.1 KB